Bielefeld, Germany

Elke Reiss-Mueller


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Elke Reiss-Mueller

Introduction

Elke Reiss-Mueller is a prominent inventor based in Bielefeld, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of neuropathic problems. Her innovative approach has led to the development of a unique method that utilizes morphine derivatives for various medical applications.

Latest Patents

Elke Reiss-Mueller holds a patent for the "Use of morphine derivatives as medicaments for the treatment of neuropathic problems." This patent describes a method for agonizing or antagonizing the ORL1 (opioid receptor-like) receptor of the nociceptin/orphanin FQ ligand ORL1 receptor system using a morphinan compound. The patent also outlines methods for treating a range of conditions, including neuropathic pain, anxiety, depression, urinary incontinence, and cognitive dysfunctions, among others. She has 1 patent to her name.

Career Highlights

Reiss-Mueller is associated with Gruenenthal GmbH, a company known for its focus on innovative pain management solutions. Her work has been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Throughout her career, Elke has collaborated with notable colleagues, including Stephan Wnendt and Wolfgang Werner Strassburger. These partnerships have contributed to her success and the impact of her inventions in the medical field.

Conclusion

Elke Reiss-Mueller's innovative work in the field of medicine showcases her dedication to improving patient care through her inventions. Her contributions continue to influence the treatment of various neuropathic conditions, highlighting the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…